Four of the 13 patients underwent germline genetic testing (31%): 2/2 patients with suspected schwannomatosis, 2/11 patients with clinically diagnosed NF1; including the patient that met clinical criteria for both NF1 and NF2. Here, NF1 is linked to schwannomatosis.